Показано 0 из 0
Дата |
---|
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.63
|
1.66
|
1.76
|
1.44
|
1.87
|
1.82
|
|
|
9 501 793.11
|
24 962.00
|
1.30
|
1.44
|
1.33
|
1.33
|
1.36
|
1.36
|
|
|
66.50
|
3.00
|
1.28
|
1.53
|
1.33
|
1.33
|
1.36
|
1.3444
|
|
|
4 214.96
|
12.00
|
1.27
|
1.44
|
1.41
|
1.33
|
1.41
|
1.37
|
|
|
1 345.96
|
9.00
|
1.31
|
1.45
|
1.42
|
1.4101
|
1.42
|
1.4101
|
|
|
1 420.00
|
4.00
|
1.25
|
1.40
|
1.36
|
1.34
|
1.38
|
1.38
|
|
|
2 737.37
|
11.00
|
1.26
|
1.49
|
1.32
|
1.30
|
1.37
|
1.37
|
|
|
2 100.00
|
9.00
|
1.26
|
1.41
|
1.44
|
1.395
|
1.45
|
1.395
|
|
|
488.82
|
9.00
|
1.27
|
1.60
|
1.43
|
1.37
|
1.43
|
1.37
|
|
|
165.91
|
5.00
|
1.01
|
1.31
|
1.43
|
1.32
|
1.43
|
1.32
|
|
|
1 177.74
|
10.00
|
Context Therapeutics Inc. is a women’s oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers.